Esophagus and Gastrointestinal Junction Tumors

Surg Clin North Am. 2020 Jun;100(3):507-521. doi: 10.1016/j.suc.2020.02.003. Epub 2020 Apr 11.

Abstract

Esophageal squamous cell carcinoma and adenocarcinoma account for 95% of all esophageal malignancies. The rates of esophageal adenocarcinoma have increased in Western countries, making it the predominant type of esophageal cancer. Treatment of both types of cancer has transformed to a more minimally invasive approach, with endoscopic methods being used for superficial cancers and more frequent use of video-assisted and laparoscopic modalities for locally advanced tumors. The current National Comprehensive Cancer Network guidelines advocate a trimodal approach to treatment, with neoadjuvant chemoradiation and surgery for locally advanced cancers.

Keywords: Esophageal adenocarcinoma; Esophageal cancer; Esophageal squamous cell carcinoma; Gastroesophageal junction cancer.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery*
  • Barrett Esophagus / complications
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / surgery*
  • Combined Modality Therapy
  • Disease Progression
  • Early Detection of Cancer
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / surgery*
  • Esophagectomy / methods
  • Esophagogastric Junction / pathology
  • Esophagogastric Junction / surgery*
  • Esophagoscopy / methods
  • Female
  • Gastroesophageal Reflux / complications
  • Humans
  • Male
  • Minimally Invasive Surgical Procedures / methods
  • Neoplasm Grading
  • Neoplasm Staging
  • Prognosis
  • Risk Factors